4//SEC Filing
ARATANA THERAPEUTICS, INC. 4
Accession 0001209191-17-003952
CIK 0001509190operating
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 6:13 PM ET
Size
7.2 KB
Accession
0001209191-17-003952
Insider Transaction Report
Form 4
TOOMAN CRAIG A
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2017-01-13+45,000→ 45,000 totalExercise: $8.02Exp: 2027-01-12→ Common Stock (45,000 underlying) - Award
Common Stock
2017-01-13+30,600→ 103,024 total
Footnotes (1)
- [F1]Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on January 29, 2018 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on January 29, 2021, subject to continued service with the Issuer through the applicable vesting dates.
Documents
Issuer
ARATANA THERAPEUTICS, INC.
CIK 0001509190
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001509190
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 6:13 PM ET
- Size
- 7.2 KB